Re: BIO Investor Forum, Oct 22-23

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

RVXoldtimer

Rank: President [?]

Points: 3190 [?]

Votes: 23 Score: 3.7 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: BIO Investor Forum, Oct 22-23

in response to

Re: BIO Investor Forum, Oct 22-23

BearDownAZ

posted on Oct 25, 2019 11:42AM

Thanks Bear - I had looked on clinicaltrials.gov last night also for the Keytruda combo trial and could find nothing. Something new is starting anyway so good! OT

6 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply